Parametric Portfolio Associates’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $604M | Buy |
5,963,843
+179,104
| +3% | +$18.8M | 0.32% | 56 |
|
|
2021
Q4 | $597M | Buy |
5,784,739
+136,999
| +2% | +$12.7M | 0.31% | 57 |
|
|
2021
Q3 | $479M | Buy |
5,647,740
+245,525
| +5% | +$20.6M | 0.27% | 62 |
|
|
2021
Q2 | $451M | Buy |
5,402,215
+282,615
| +6% | +$23.1M | 0.25% | 72 |
|
|
2021
Q1 | $385M | Sell |
5,119,600
-188,636
| -4% | -$13.7M | 0.22% | 71 |
|
|
2020
Q4 | $363M | Sell |
5,308,236
-31,679
| -0.6% | -$2.06M | 0.23% | 67 |
|
|
2020
Q3 | $312M | Sell |
5,339,915
-428,927
| -7% | -$26.7M | 0.22% | 72 |
|
|
2020
Q2 | $375M | Sell |
5,768,842
-12,831
| -0.2% | -$808K | 0.29% | 58 |
|
|
2020
Q1 | $343M | Buy |
5,781,673
+237,302
| +4% | +$15.8M | 0.31% | 56 |
|
|
2019
Q4 | $412M | Buy |
5,544,371
+29,269
| +0.5% | +$2.06M | 0.3% | 54 |
|
|
2019
Q3 | $348M | Buy |
5,515,102
+364,422
| +7% | +$21.6M | 0.28% | 55 |
|
|
2019
Q2 | $281M | Buy |
5,150,680
+847,460
| +20% | +$45.6M | 0.23% | 73 |
|
|
2019
Q1 | $232M | Sell |
4,303,220
-1,194,686
| -22% | -$73.7M | 0.2% | 81 |
|
|
2018
Q4 | $360M | Buy |
5,497,906
+1,196,326
| +28% | +$89.3M | 0.36% | 42 |
|
|
2018
Q3 | $339M | Buy |
4,301,580
+225,000
| +6% | +$16.1M | 0.3% | 56 |
|
|
2018
Q2 | $262M | Buy |
4,076,580
+460,699
| +13% | +$30.4M | 0.25% | 66 |
|
|
2018
Q1 | $225M | Sell |
3,615,881
-2,693
| -0.1% | -$193K | 0.22% | 71 |
|
|
2017
Q4 | $262M | Sell |
3,618,574
-590,404
| -14% | -$42.9M | 0.26% | 61 |
|
|
2017
Q3 | $342M | Buy |
4,208,978
+343,543
| +9% | +$27.2M | 0.37% | 44 |
|
|
2017
Q2 | $311M | Buy |
3,865,435
+1,562,749
| +68% | +$123M | 0.37% | 43 |
|
|
2017
Q1 | $181M | Sell |
2,302,686
-760,907
| -25% | -$60.7M | 0.28% | 49 |
|
|
2016
Q4 | $242M | Buy |
3,063,593
+318,364
| +12% | +$25.8M | 0.34% | 47 |
|
|
2016
Q3 | $244M | Buy |
2,745,229
+24,021
| +0.9% | +$2.27M | 0.37% | 45 |
|
|
2016
Q2 | $261M | Sell |
2,721,208
-31,711
| -1% | -$3.16M | 0.41% | 39 |
|
|
2016
Q1 | $286M | Sell |
2,752,919
-234,514
| -8% | -$22.8M | 0.46% | 33 |
|
|
2015
Q4 | $292M | Sell |
2,987,433
-38,175
| -1% | -$3.74M | 0.5% | 31 |
|
|
2015
Q3 | $292M | Buy |
3,025,608
+487,098
| +19% | +$51.2M | 0.57% | 27 |
|
|
2015
Q2 | $266M | Buy |
2,538,510
+13,639
| +0.5% | +$1.39M | 0.52% | 30 |
|
|
2015
Q1 | $261M | Buy |
2,524,871
+30,494
| +1% | +$3.09M | 0.52% | 25 |
|
|
2014
Q4 | $240M | Sell |
2,494,377
-43,651
| -2% | -$3.85M | 0.51% | 27 |
|
|
2014
Q3 | $202M | Sell |
2,538,028
-14,417
| -0.6% | -$1.14M | 0.45% | 35 |
|
|
2014
Q2 | $192M | Sell |
2,552,445
-44,687
| -2% | -$3.38M | 0.43% | 35 |
|
|
2014
Q1 | $194M | Sell |
2,597,132
-124,957
| -5% | -$8.83M | 0.46% | 33 |
|
|
2013
Q4 | $195M | Sell |
2,722,089
-18,287
| -0.7% | -$1.17M | 0.47% | 33 |
|
|
2013
Q3 | $156M | Sell |
2,740,376
-73,062
| -3% | -$4.35M | 0.42% | 38 |
|
|
2013
Q2 | $161M | Buy |
+2,813,438
| New | +$163M | 0.47% | 32 |
|
Other funds holding CVS
Parametric Portfolio Associates's CVS Position: Q1 2022 in Review
Parametric Portfolio Associates increased its CVS Health (CVS) stake by 3.1% in Q1 2022, buying an estimated $18.8M and bringing the position to 5,963,843 shares worth $604M. The position accounts for 0.32% of the portfolio, ranked #56.
Parametric Portfolio Associates first reported a position in CVS in Q2 2013 and has held it in 36 quarters since. 2,365 funds tracked by Wall St. Rank hold CVS as of Q1 2022.
- Parametric Portfolio Associates held 5,963,843 shares of CVS Health worth $604M as of Q1 2022.
- Parametric Portfolio Associates bought 179,104 CVS Health shares in Q1 2022, an estimated $18.8M.
- CVS Health made up 0.32% of Parametric Portfolio Associates's portfolio in Q1 2022, its #56 holding.
- Parametric Portfolio Associates first reported a position in CVS Health in Q2 2013 and has held it in 36 quarters since.
- 2,365 funds tracked by Wall St. Rank held CVS Health as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.